pI: 5.9314 |
Length (AA): 810 |
MW (Da): 91815 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
384 | 707 | 1nex (B) | 387 | 675 | 18.00 | 0 | 1 | 0.38 | 0.3 |
565 | 744 | 2aq5 (A) | 79 | 263 | 18.00 | 0.0000000038 | 0.72 | 0.37 | -0.37 |
549 | 758 | 4ycz (A) | 45 | 269 | 27.00 | 0.045 | 0.97 | 0.414259 | 0.46 |
564 | 639 | 5nnz (B) | 131 | 206 | 30.00 | 0.14 | 0.92 | 0.492827 | -0.33 |
565 | 691 | 4zoz (A) | 63 | 221 | 24.00 | 0.87 | 0.64 | 0.42479 | -0.3 |
566 | 639 | 4j82 (A) | 227 | 300 | 19.00 | 0 | 0.27 | 0.321258 | -0.41 |
566 | 652 | 3mmy (A) | 85 | 169 | 34.00 | 0.0013 | 0.88 | 0.522407 | -0.33 |
570 | 637 | 4ci8 (A) | 374 | 444 | 29.00 | 0.56 | 0.79 | 0.432951 | -0.26 |
607 | 664 | 4jsn (D) | 126 | 180 | 35.00 | 0.66 | 0.73 | 0.417605 | 0.21 |
611 | 782 | 3g4e (A) | 11 | 150 | 31.00 | 0.79 | 0.12 | 0.0953457 | 1.13 |
713 | 807 | 4tql (A) | 96 | 193 | 16.00 | 0.11 | 0.04 | 0.324084 | -0.64 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_130347)
Species | Accession | Gene Product |
---|---|---|
Drosophila melanogaster | Dmel_CG14838 | CG14838 gene product from transcript CG14838-RA |
Echinococcus granulosus | EgrG_000099200 | Mitochondrial import receptor subunit TOM20 |
Echinococcus granulosus | EgrG_000331000 | WD repeat containing protein 63 |
Echinococcus multilocularis | EmuJ_000331000 | WD repeat containing protein 63 |
Echinococcus multilocularis | EmuJ_000099200 | Mitochondrial import receptor subunit TOM20 |
Homo sapiens | ENSG00000162643 | WD repeat domain 63 |
Leishmania braziliensis | LbrM.27.1760 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_271530.1 | inner dynein arm I1 intermediate chain, axonemal |
Leishmania infantum | LinJ.27.1530 | hypothetical protein, conserved |
Leishmania major | LmjF.27.1630 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.27.1630 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000043020 | WD repeat domain 63 |
Neospora caninum | NCLIV_049070 | hypothtetical protein, conserved, putative |
Plasmodium berghei | PBANKA_0520700 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_1037800 | dynein intermediate chain, putative |
Plasmodium knowlesi | PKNH_0622300 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_110865 | hypothetical protein, conserved |
Plasmodium yoelii | PY03524 | hypothetical protein |
Plasmodium yoelii | PY03525 | hypothetical protein |
Schistosoma japonicum | Sjp_0094080 | similar to Dynein, 70 kDa intermediate chain, flagellar outer arm, putative |
Schistosoma japonicum | Sjp_0093820 | IPR001680,WD-40 repeat;IPR011046,WD40-like,domain-containing |
Schistosoma japonicum | Sjp_0216660 | Mitochondrial import receptor subunit TOM20 homolog, putative |
Schistosoma mansoni | Smp_136210 | testis development protein nyd-sp29 |
Schmidtea mediterranea | mk4.022739.00 | Putative testis development protein nyd-sp29 |
Schmidtea mediterranea | mk4.013525.00 | |
Schmidtea mediterranea | mk4.000807.06 | |
Trypanosoma brucei gambiense | Tbg972.11.2520 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.2270 | inner dynein arm I1 intermediate chain, axonemal |
Trypanosoma congolense | TcIL3000.11.2020 | inner dynein arm I1 intermediate chain, axonemal |
Trypanosoma cruzi | TcCLB.503593.20 | inner dynein arm I1 intermediate chain, axonemal |
Trypanosoma cruzi | TcCLB.506127.160 | inner dynein arm I1 intermediate chain, axonemal |
Toxoplasma gondii | TGME49_223262 | WD domain, G-beta repeat-containing protein |
Trichomonas vaginalis | TVAG_299420 | testis development protein nyd-sp29, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.18.0003 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.18.0003 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.18.0003 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.18.0003 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_223262 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.